Dr. Patrick Soon-Shiong, a physician and entrepreneur, is the visionary behind NantKwest, Inc., a biotech firm dedicated to pioneering immunotherapy for cancer treatment. His investment portfolio includes CureVac and Aduro Biotech, an interest in advancing cancer-related innovations.